Treatment of Chronic Widespread Pain in Connective Tissue Disorders

Introduction to Treatment Options

The American College of Physicians recommends a multimodal approach using antidepressants, physical therapy, and psychological interventions for patients with chronic widespread pain due to connective tissue disorders 1, 2

Fibromyalgia is characterized by generalized, widespread chronic pain with multiple tender points upon physical examination, believed to result from central sensitization, as stated by the American College of Rheumatology 1, 2
Rheumatoid arthritis can present with widespread pain, especially when accompanied by central pain amplification, according to the Mayo Clinic Proceedings 3

The FDA-approved medications for fibromyalgia include pregabalin, duloxetine, and milnacipran, as recommended by the American Academy of Neurology 1, 4
First-line treatments for neuropathic pain components include antidepressants, α2-δ calcium channel ligand anticonvulsants, and topical lidocaine, as suggested by the International Association for the Study of Pain 1, 2
NSAIDs and acetaminophen are recommended for inflammatory and nociceptive pain, according to the American College of Physicians 1, 2

Cognitive behavioral therapy is recommended to address pain catastrophizing and develop coping strategies, as stated by the American Psychological Association 5, 6
Regular physical activity tailored to the patient's capabilities is recommended, according to the American College of Sports Medicine 1, 7

The treatment algorithm should identify pain mechanisms, including neuropathic, nociceptive, or mixed pain, and assess for central sensitization features, as recommended by the American Academy of Neurology 1
Initial treatment should be based on the predominant pain mechanism, with options including pregabalin, duloxetine, and gabapentin, as suggested by the Mayo Clinic Proceedings 1, 4

Opioids should be considered second-line treatments for neuropathic pain, according to the International Association for the Study of Pain 1, 2
Patients with chronic pain often have comorbid depression and anxiety that should be addressed concurrently, as stated by the American Psychiatric Association 1, 6

Focusing solely on pharmacological management without addressing physical function and psychological factors should be avoided, as recommended by the American College of Physicians 5, 6
Overreliance on opioids, which have limited evidence for long-term effectiveness in chronic non-cancer pain, should be avoided, according to the Centers for Disease Control and Prevention 1, 8